Experimental Drug Shows Promise Against Type 2 Diabetes (HealthDay)
HealthDay – SUNDAY, Feb. 26 (HealthDay News) — An experimental drug improves
patients’ blood sugar control without increasing the risk of low blood
sugar (hypoglycemia) in patients with type 2 diabetes, according to the
results of a phase 2 clinical trial.